Please use this identifier to cite or link to this item:
https://hdl.handle.net/20.500.14365/4717
Title: | Real-World Evaluation of Anticoagulant Treatment Patterns in Patients with Atrial Fibrillation: Data from Multicenter ROTA Study [2023] | Authors: | Kocabas, Umut Ergin, Isil Yavuz, Veysel Murat, Selda Özdemir, İbrahim Genç, Ömer Altın, Cihan |
Keywords: | Atrial fibrillation anticoagulation direct oral anticoagulants stroke systemic embolism Antagonist Oral Anticoagulants Stroke Prevention European-Society Warfarin Guidelines Management Outcomes Adherence |
Publisher: | Kare Publ | Abstract: | Objective: Oral anticoagulant therapy is the cornerstone of atrial fibrillation management to prevent stroke and systemic embolism. However, there is limited real-world information regarding stroke and systemic embolism prevention strategies in patients with atrial fibrillation. The aim of the ROTA study is to obtain the real-world data of anticoagulant treatment patterns in patients with atrial fibrillation. Materials and Methods: The ROTA study is a prospective, multicenter, and observational study that included 2597 patients with atrial fibrillation. The study population was recruited from 41 cardiology outpatient clinics between January 2021 and May 2021.Results: The median age of the study population was 72 years (range: 22-98 years) and 57.4% were female. The median CHA2DS2-VASc and HAS-BLED scores were 4 (range: 0-9) and 1 (range: 0-6), respectively. Vitamin K antagonists and direct oral anticoagulants were used in 15.9% and 79.4% of patients, respectively. The mean time in therapeutic range was 52.9% for patients receiving vitamin K antagonists, and 76% of those patients had an inadequate time in therapeutic range with <70%. The most common prescribed direct oral anticoagulants were rivaroxaban (38.1%), apixaban (25.5%), and edoxaban (11.2%). The rate of overuse of vitamin K antagonists and direct oral anticoagulants was high (76.1%) in patients with low stroke risk, and more than one-fourth of patients on direct oral anticoagulant therapy were receiving a reduced dose of direct oral anticoagulants. Among patients who were on direct oral anticoagulant treatment, patients with apixaban treatment were older, had higher CHA2DS2- VASc and HAS-BLED scores, and had lower creatinine clearance than the patients receiving other direct oral anticoagulants.Conclusions: The ROTA study provides important real-world information about anticoagulant treatment patterns in patients with atrial fibrillation. | URI: | https://doi.org/10.5543/tkda.2022.98455 https://search.trdizin.gov.tr/yayin/detay/1169237 https://hdl.handle.net/20.500.14365/4717 |
ISSN: | 1016-5169 1308-4488 |
Appears in Collections: | PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection TR Dizin İndeksli Yayınlar Koleksiyonu / TR Dizin Indexed Publications Collection WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
Files in This Item:
File | Size | Format | |
---|---|---|---|
KOCABAS.pdf | 2.35 MB | Adobe PDF | View/Open |
CORE Recommender
SCOPUSTM
Citations
2
checked on Sep 11, 2024
WEB OF SCIENCETM
Citations
2
checked on Sep 11, 2024
Page view(s)
276
checked on Aug 19, 2024
Download(s)
86
checked on Aug 19, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.